Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patients.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Clinical Nutrition

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/AJCN/62.6.1268PMID 7491891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in cystic fibrosis research.

  1993cited by this paper
• Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4.

  1993cited by this paper
• The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells.

  1992cited by this paper
• Cystic fibrosis: beyond the gene to therapy.

  1992cited by this paper
• Desaturation of linoleic acid in the small bowel is increased by short-term fasting and by dietary content of linoleic acid.

  1992cited by this paper
• The bentiromide test using plasma p-aminobenzoic acid for diagnosing pancreatic insufficiency in young children. The effect of two different doses and a liquid meal.

  1991cited by this paper
• Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

  1991cited by this paper
• Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation

  1991cited by this paper
• The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

  1990cited by this paper
• Abnormal regulation of ion channels in cystic fibrosis epithelia

  1990cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients.

  1989cited by this paper
• Effect of dietary cholesterol and/or omega 3 fatty acids on lipid composition and delta 5-desaturase activity of rat liver microsomes.

  1988cited by this paper
• Supplemental Calories Improve Essential Fatty Acid Deficiency in Cystic Fibrosis Patients

  1988cited by this paper
• Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis.

  1988cited by this paper
• Delta 6-desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or omega 3 fatty acids.

  1988cited by this paper
• Phosphatidylethanolamine methyltransferase: evidence for influence of diet fat on selectivity of substrate for methylation in rat brain synaptic plasma membranes.

  1987cited by this paper
• Platelet function in patients with cystic fibrosis

  1986cited by this paper
• Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency.

  1985cited by this paper
• Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids.

  1985cited by this paper
• Fatty Acid Abnormalities in Cystic Fibrosis

  1985cited by this paper
• Quantitative relationships between dietary linoleate and prostaglandin (Eicosanoid) biosynthesis

  1985cited by this paper
• Effects of essential fatty acids on prostaglandin biosynthesis.

  1984cited by this paper
• Effects of essential fatty acids on prostaglandin biosynthesis.

  1984cited by this paper
• Abnormal Fatty Acid Turnover in the Phospholipids of the Red Blood Cell Membranes of Cystic Fibrosis Patients (in Vitro Study)

  1984cited by this paper
• Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency

  1983cited by this paper
• What is the association of essential fatty acid status with cystic fibrosis?

  1983cited by this paper
• Essential fatty acid deficiency and brain development.

  1982cited by this paper
• Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation.

  1981cited by this paper
• Early effects of EFA deficiency on the structure and enzymatic activity of rat liver microsomes.

  1981cited by this paper
• Bowes' and Church's Food Values of Portions Commonly Used

  1980cited by this paper
• Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis.

  1980cited by this paper
• Physical growth: National Center for Health Statistics percentiles.

  1979cited by this paper
• Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis.

  1978cited by this paper
• PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

  1964cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper
• THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

  1945cited by this paper
• A NEW COUPLING COMPONENT FOR SULFANILAMIDE DETERMINATION

  1939cited by this paper

• Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial

  2023cites this paper
• Unsaturated Fatty Acids in Cystic Fibrosis: Metabolism and Therapy

  2015cites this paper
• Long-chain PUFA in Granulocytes, Mononuclear Cells, and RBC in Patients With Cystic Fibrosis: Relation to Liver Disease

  2012cites this paper
• Importance du stress oxydant dans le diabète secondaire à la fibrose kystique

  2010cites this paper
• Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids.

  2010cites this paper
• A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients

  2009cites this paper
• Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

  2009cites this paper
• Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism.

  2008cites this paper
• Nutritional Support in Hereditary Disease

  2008cites this paper
• Plasma fatty acids and lipid hydroperoxides increase after antibiotic treatment in cystic fibrosis Plasma fatty acids in cystic fibrosis

  2007cites this paper
• Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis

  2007cites this paper
• Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.

  2007cites this paper
• Fetal Lipid Requirements : Implications in Fetal Growth Retardation

  2006cites this paper
• Applied nutritional investigation Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study

  2006cites this paper
• Dietary and Circulating Polyunsaturated Fatty Acids in Cystic Fibrosis: Are They Related to Clinical Outcomes?

  2006cites this paper
• Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.

  2006cites this paper
• Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.

  2006influential citation
• Antiinflammatory Therapies for Cystic Fibrosis: Past, Present, and Future

  2005cites this paper
• Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency

  2005cites this paper
• Heparin can improve the viability of transfected cystic fibrosis cell lines in vitro.

  2004cites this paper
• Approaches to Pharmacological Treatment and Gene Therapy of Cystic Fibrosis

  2004cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1312 Approaches to Pharmacological Treatment and Gene Therapy of Cystic Fibrosis

  2004cites this paper
• Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.

  2003cites this paper
• Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitus

  2003cites this paper
• Abnormal lipid concentrations in cystic fibrosis.

  2002cites this paper
• Mechanisms of insulin resistance in cystic fibrosis.

  2001cites this paper
• Role of polyunsaturated fatty acids in lung disease.

  2000cites this paper
• The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.

  2000cites this paper
• The D F508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Alters Control of Essential Fatty Acid Utilization in Epithelial Cells 1

  2000cites this paper
• Modifications of alpha-tocopherol and fatty acid concentrations in blood and adipose tissue of obese patients during a weight loss programme.

  1999cites this paper
• Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in preterm infant formulas on the fatty acid content of lipoprotein lipids

  1999cites this paper
• Symposium Session Summaries: Sessions 8.4 to 13.3

  1998cites this paper
• Omega-3 fatty acid intake results in a relationship between the fatty acid composition of LDL cholesterol ester and LDL cholesterol content in humans.

  1997cites this paper
• Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis

  1996cites this paper
• Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels.

  1996cites this paper